IP Library › Granted Patent US 11,064,920
Granted Patent B2
US 11,064,920 · App. 16/057,189 · Granted Jul 20, 2021

Brain clot characterization using optical signal analysis, and corresponding stent selection

Inventor: Assaf Govari (Haifa, IL)
Assignee: Biosense Webster (Israel) Ltd.
A61B5/1459A61B1/07A61B5/062A61B5/14535A61B5/4064A61B5/4836A61B5/6876A61B17/22A61B2017/00057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,064,920
App. No.
16/057,189
Granted
Jul 20, 2021
Kind
B2
Abstract

A medical system includes a probe, an electrooptical measurement unit, and a processor. The probe, which is configured for insertion into a blood vessel of a brain, includes one or more optical fibers configured to guide an optical signal to interact with a brain clot in the blood vessel, and to output the optical signal that interacted with the brain clot. The electrooptical measurement unit is configured to collect and measure the outputted optical signal. The processor is configured to identify a composition of the brain clot by analyzing the measured optical signal from the probe.

Claims (24)

1. A medical system, comprising:

a probe for insertion into a blood vessel of a brain, the probe comprising one or more optical fibers configured to guide an optical signal to interact with a brain clot in the blood vessel, and to output the optical signal that interacted with the brain clot;

an electrooptical measurement unit, configured to collect and measure the outputted optical signal to produce a measured optical signal; and

a processor, configured to identify a composition of the brain clot by analyzing the measured optical signal from the probe;

wherein the processor is configured to identify, based on the measured optical signal, whether the composition of the brain clot is characterized by a preponderance of red blood cells or by white blood cells; and

wherein the processor is configured to output a recommendation, based on whether the composition of the brain clot is characterized by the preponderance of red blood cells or by white blood cells, for selecting a brain-clot removal device that matches the composition of the brain clot.

2. The medical system according to claim 1 , wherein the processor is configured to identify the composition of the brain clot based on an intensity of the measured optical signal.

3. The medical system according to claim 1 , wherein the optical signal comprises monochromatic red light.

4. The medical system according to claim 1 , further comprising an optical sensor fitted at a distal end of at least one of the one or more optical fibers.

5. The medical system according to claim 4 , wherein the optical sensor comprises a Bragg grating sensor configured to reflect a monochromatic red light.

6. The medical system according to claim 1 , wherein the one or more optical fibers guide the optical signal to be transmitted via the brain clot, or to be reflected from the brain clot.

7. The medical system according to claim 1 , further comprising a clot removal device fitted at a distal end of the probe.

8. A method, comprising:

guiding an optical signal via one or more optical fibers in a probe that is inserted into a blood vessel of a brain, to interact with a brain clot in the blood vessel;

collecting from the probe and measuring an outputted optical signal that interacted with the brain clot;

identifying a composition of the brain clot via a processor, by analyzing the measured optical signal from the probe and analyzing whether the composition is characterized by a preponderance of red blood cells or by white blood cells;

recommending via the processor a brain-clot removal device that matches the composition of the brain clot;

selecting a brain-clot removal device based on the identified composition of the clot and recommendation via the processor; and

removing the clot using the selected brain-clot removal device.

9. The method according to claim 8 , wherein identifying the composition of the brain clot comprises identifying the composition of the brain clot based on an intensity of the optical signal.

10. The method according to claim 8 , wherein collecting the outputted optical signal comprises collecting an outputted monochromatic red light.

11. The method according to claim 8 , wherein collecting the outputted optical signal comprises collecting the optical signal outputted from an optical sensor fitted at a distal end of at least one of the one or more optical fibers.

12. The method according to claim 11 , wherein collecting the optical signal outputted from the optical sensor comprises collecting monochromatic red light reflected by a Bragg grating sensor.

13. The method according to claim 8 , wherein guiding the optical signal comprises transmitting the optical signal to the brain clot, or reflecting the optical signal from the brain clot.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2019
From: GOVARI, ASSAF
To: BIOSENSE WEBSTER (ISRAEL) LTD.
Reel/Frame 049981/0988 →
Continuity (1)
Related Publication 20200046267A1 · Feb 13, 2020